fda warning on semaglutide 🚨 PUBLIC HEALTH WARNING🚨 HINDI kabilang sa FDA-approved medicines ang compounded na GLP-1 RA tulad ng at Tirzepatide. ❌ Hindi pa napatutunayan ang bisa at kaligtasan nito kumpara sa aprubadong gamot FDA Warns on Certain Forms

Monitoring considerations include: Regular assessment of gastrointestinal tolerability and hydration status Evaluation of any changes in MS symptoms, with low threshold for neurological consultation Glucose monitoring in diabetic patients, with adjustment of other antihyperglycemic agents as needed Periodic assessment of weight loss progress and nutritional adequacy Monitoring for signs of pancreatitis (severe abdominal pain) or gallbladder disease For Wegovy patients, monitoring for depression or suicidal thoughts Patient counseling should address realistic expectations regarding weight loss (typically 15% of body weight over 68 weeks with the 2.4 mg dose plus lifestyle intervention, with less at earlier timepoints), the chronic nature of therapy, and the importance of lifestyle modifications

2023;10:e2300414

Sermorelin ODT: Dissolves under the tongue - no injections required

So, do Kind Patches actually work

Consoli A, Formoso G, Baldassarre MPA, et al

La L-carnitina coinvolta nel metabolismo degli acidi grassi, ma la perdita di peso dipende da un bilancio calorico negativo e da una dieta equilibrata